N-methyl-N-dithiocarboxyglucamine sodium MDCG sodium,98.60%
产品编号:Bellancom-111054A| CAS NO:91840-27-6| 分子式:C8H16NNaO5S2| 分子量:293.34
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
N-methyl-N-dithiocarboxyglucamine sodium MDCG sodium
产品介绍 | N-methyl-N-dithiocarboxyglucamine (MDCG) sodium 在小鼠模型中动员并促进金属硫蛋白结合 109Cd 的排泄。N-methyl-N-dithiocarboxyglucamine 显著降低肝脏和肾脏的镉含量,而肝脏和肾脏是最易受镉诱导的毒性影响的器官。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | N-methyl-N-dithiocarboxyglucamine (MDCG) sodium mobilizes and promotes excretion of metallothionein-bound 109Cd in mouse model. N-methyl-N-dithiocarboxyglucamine significantly lowers the Cd content of both the liver and kidney, which is organs most susceptible to Cd-induced toxicity. | ||||||||||||||||
体外研究 | |||||||||||||||||
体内研究 |
N-methyl-N-dithiocarboxyglucamine (1.1 mM/kg;腹腔注射;单剂量) 可显著诱导 Cd 从粪便排泄。而增加处理次数到每周 7 次后,导致小鼠全身 Cd 负荷减少了 50% 以上。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
N-methyl-N-dithiocarboxyglucamine (1.1 mM/kg;腹腔注射;单剂量) 可显著诱导 Cd 从粪便排泄。而增加处理次数到每周 7 次后,导致小鼠全身 Cd 负荷减少了 50% 以上。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 62.5 mg/mL (213.06 mM; ultrasonic and warming and heat to 60°C) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
参考文献 |